SEA MILLS SURGERY
2 RIVERLEAZE, SEA MILLS, BRISTOL
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 78 | 104 | 75.0% | |
| STROKE 9 | 2006 | 107 | 110 | 97.3% | |
| Stroke 12 | 2007 | 100 | 102 | 98.0% | |
| Stroke 12 | 2008 | 101 | 104 | 97.1% | |
| Stroke 12 | 2009 | 114 | 120 | 95.0% | |
| Stroke 12 | 2010 | 116 | 125 | 92.8% | |
| STROKE 12 | 2011 | 116 | 120 | 96.7% | |
| STROKE 12 | 2012 | 114 | 119 | 95.8% | |
| STROKE 12 | 2013 | 113 | 120 | 94.2% | |
| STIA007 | 2014 | 118 | 124 | 95.2% | |
| STIA007 | 2015 | 114 | 116 | 98.3% | |
| STIA007 | 2016 | 108 | 117 | 92.3% | |
| STIA007 | 2017 | 106 | 113 | 93.8% | |
| STIA007 | 2018 | 97 | 97 | 100.0% | |
| STIA007 | 2019 | 105 | 111 | 94.6% | |
| STIA007 | 2020 | 100 | 103 | 97.1% | |
| STIA007 | 2021 | 96 | 97 | 99.0% | |
| STIA007 | 2022 | 113 | 115 | 98.3% | |
| STIA007 | 2023 | 126 | 133 | 94.7% |
